Skip to main content
. 2024 Dec 7;2024:2221976. doi: 10.1155/ije/2221976

Table 1.

Participants characteristics by serum uric acid (N = 583).

Characteristic ≤ 360 > 360, ≤ 420 > 420 p
N 277 (47.51) 97 (16.64) 209 (35.85)
Age, year 67.99 ± 10.41 66.63 ± 9.39 65.75 ± 11.31 0.267
Gender, n (%) < 0.001
 Male 137 (49.46) 67 (69.07) 129 (61.72)
 Female 140 (50.54) 30 (30.93) 80 (38.28)
Degree of education, n (%) 0.101
 Illiterate 100 (36.10) 29 (29.90) 61 (29.19)
 Primary school 125 (45.13) 41 (42.27) 111 (53.11)
 Junior school 30 (10.83) 20 (20.62) 23 (11.00)
 High school and above 22 (7.94) 7 (7.22) 14 (6.70)
Marital status, n (%) 0.015
 Unmarried 2 (0.72) 0 (0.00) 0 (0.00)
 Married 248 (89.53) 82 (84.54) 177 (84.69)
 Divorce 0 (0.00) 2 (2.06) 0 (0.00)
 Widowed 27 (9.75) 13 (13.40) 32 (15.31)
Smoke, n (%) 0.454
 Nonsmoker 170 (61.37) 53 (54.64) 121 (57.89)
 Current smoker 51 (18.41) 26 (26.80) 49 (23.44)
 Quit 56 (20.22) 18 (18.56) 39 (18.66)
Alcohol consumption, n (%) 0.051
 Nondrinker 211 (76.17) 61 (62.89) 144 (68.90)
 Current drinker 46 (16.61) 26 (26.80) 39 (18.66)
 Quit 20 (7.22) 10 (10.31) 26 (12.44)
Valvular heart disease, n (%) 0.126
 No 192 (69.31) 68 (70.10) 128 (61.24)
 Yes 85 (30.69) 29 (29.90) 81 (38.76)
Hypertension, n (%) 0.176
 No 136 (49.10) 37 (38.14) 96 (45.93)
 Yes 141 (50.90) 60 (61.86) 113 (54.07)
Diabetes, n (%) 0.008
 No 218 (78.70) 61 (62.89) 158 (75.60)
 Yes 59 (21.30) 36 (37.11) 51 (24.40)
Heart failure, n (%) < 0.001
 No 144 (51.99) 32 (32.99) 65 (31.10)
 Yes 133 (48.01) 65 (67.01) 144 (68.90)
Coronary heart disease, n (%) < 0.001
 No 48 (17.33) 15 (15.46) 64 (30.62)
 Yes 229 (82.67) 82 (84.54) 145 (69.38)
Myocardial infarction, n (%) 0.004
 No 246 (88.81) 91 (93.81) 202 (96.65)
 Yes 31 (11.19) 6 (6.19) 7 (3.35)
Hyperlipidemia, n (%) 0.567
 No 267 (96.39) 94 (96.91) 198 (94.74)
 Yes 10 (3.61) 3 (3.09) 11 (5.26)
Cerebral infarction, n (%) 0.537
 No 237 (85.56) 81 (83.51) 171 (81.82)
 Yes 40 (14.44) 16 (16.49) 38 (18.18)
Aspirin, n (%) 0.036
 No 171 (61.73%) 58 (59.79) 150 (71.77)
 Yes 106 (38.27%) 39 (40.21) 59 (28.23)
Warfarin, n (%) 0.166
 No 239 (86.28) 83 (85.57) 191 (91.39)
 Yes 38 (13.72) 14 (14.43) 18 (8.61)
Clopidogrel, n (%) 0.937
 No 257 (92.78) 89 (91.75) 194 (92.82)
 Yes 20 (7.22) 8 (8.25) 15 (7.18)
Amiodarone, n (%) 0.050
 No 269 (97.11) 95 (97.94) 209 (100.00)
 Yes 8 (2.89) 2 (2.06) 0 (0.00)
Type of atrial fibrillation, n (%) 0.066
 Paroxysmal 87 (31.41) 29 (29.90) 48 (22.97)
 Persistent 126 (45.49) 53 (54.64) 116 (55.50)
 Long-standing persistent 32 (11.55) 3 (3.09) 18 (8.61)
 Permanent 32 (11.55) 12 (12.37) 27 (12.92)
Body mass index (kg/m2) 24.87 ± 3.48 26.27 ± 4.22 25.66 ± 5.14 0.005
Red blood cell (1012/L) 4.42 ± 0.55 4.56 ± 0.73 4.32 ± 0.72 0.054
Hemoglobin (g/L) 135.65 ± 16.53 140.72 ± 20.15 132.07 ± 23.85 0.016
White blood cell (109/L) 7.11 ± 3.37 7.29 ± 2.68 7.03 ± 2.36 0.480
Platelets (109/L) 219.07 ± 67.74 191.80 ± 61.36 196.88 ± 66.39 <0.001
Free triiodothyronine (pmol/L) 4.33 (2.13, 31.80) 4.17 (1.95, 7.04) 4.11 ± 0.99 <0.001
Free thyroxine (pmol/L) 18.70 ± 9.12 18.20 (3.72, 100.00) 18.22 ± 3.16 0.203
Creatinine (umol/L) 64.48 ± 18.22 74.56 ± 24.86 85.29 ± 23.95 <0.001
Left ventricular ejection fraction (%) 53.19 ± 9.48 46.52 ± 13.85 47.18 ± 13.12 <0.001
Left atrial diameter (mm) 45.48 ± 9.17 49.45 ± 7.92 49.29 ± 10.22 <0.001
MoCA 19.06 ± 7.01 20.25 ± 6.14 19.37 ± 6.84 0.388